These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26562841)

  • 1. Diversity of Mycobacterium tuberculosis across Evolutionary Scales.
    O'Neill MB; Mortimer TD; Pepperell CS
    PLoS Pathog; 2015; 11(11):e1005257. PubMed ID: 26562841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of selection in shaping diversity of natural M. tuberculosis populations.
    Pepperell CS; Casto AM; Kitchen A; Granka JM; Cornejo OE; Holmes EC; Birren B; Galagan J; Feldman MW
    PLoS Pathog; 2013 Aug; 9(8):e1003543. PubMed ID: 23966858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The arms race between man and Mycobacterium tuberculosis: Time to regroup.
    Hoal EG; Dippenaar A; Kinnear C; van Helden PD; Möller M
    Infect Genet Evol; 2018 Dec; 66():361-375. PubMed ID: 28843547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy.
    Trauner A; Liu Q; Via LE; Liu X; Ruan X; Liang L; Shi H; Chen Y; Wang Z; Liang R; Zhang W; Wei W; Gao J; Sun G; Brites D; England K; Zhang G; Gagneux S; Barry CE; Gao Q
    Genome Biol; 2017 Apr; 18(1):71. PubMed ID: 28424085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host.
    Torrelles JB; Schlesinger LS
    Tuberculosis (Edinb); 2010 Mar; 90(2):84-93. PubMed ID: 20199890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.
    Gautam SS; Mac Aogáin M; Cooley LA; Haug G; Fyfe JA; Globan M; O'Toole RF
    PLoS One; 2018; 13(2):e0192351. PubMed ID: 29466411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Future prospects of molecular epidemiology in tuberculosis].
    Matsumoto T; Iwamoto T
    Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.
    Jackson M; McNeil MR; Brennan PJ
    Future Microbiol; 2013 Jul; 8(7):855-75. PubMed ID: 23841633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection caused by Mycobacterium tuberculosis.
    Peloquin CA; Berning SE
    Ann Pharmacother; 1994 Jan; 28(1):72-84. PubMed ID: 8123968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Population structure analysis of Mycobacterium tuberculosis Beijing family in Japan].
    Iwamoto T
    Kekkaku; 2009 Dec; 84(12):755-9. PubMed ID: 20077859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.
    Asalla S; Mohareer K; Banerjee S
    Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283
    [No Abstract]   [Full Text] [Related]  

  • 15. Human and tuberculosis co-evolution: An integrative view.
    Perrin P
    Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S112-6. PubMed ID: 25841342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Host, Sample, and
    Shockey AC; Dabney J; Pepperell CS
    Front Genet; 2019; 10():477. PubMed ID: 31214242
    [No Abstract]   [Full Text] [Related]  

  • 17. Epigenetic code during mycobacterial infections: therapeutic implications for tuberculosis.
    Fatima S; Kumari A; Agarwal M; Pahuja I; Yadav V; Dwivedi VP; Bhaskar A
    FEBS J; 2022 Jul; 289(14):4172-4191. PubMed ID: 34453865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development.
    Le Chevalier F; Cascioferro A; Majlessi L; Herrmann JL; Brosch R
    Future Microbiol; 2014; 9(8):969-85. PubMed ID: 25302954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus.
    Wollenberg KR; Desjardins CA; Zalutskaya A; Slodovnikova V; Oler AJ; Quiñones M; Abeel T; Chapman SB; Tartakovsky M; Gabrielian A; Hoffner S; Skrahin A; Birren BW; Rosenthal A; Skrahina A; Earl AM
    J Clin Microbiol; 2017 Feb; 55(2):457-469. PubMed ID: 27903602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
    Hudson SA; McLean KJ; Munro AW; Abell C
    Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.